CD8A and neoplasm: Similarly, a cell-cell adhesion assay confirmed that PKH26-labeled CD8+ cells had a higher tendency to adhere to PKH67-labeled tumor cells after overexpressing G9 in NPC (NPC43OE6) versus the knockdown group (C17KD4; Supplementary Fig 2B).